Contineum Therapeutics Competitors and Similar CompaniesClear all
Contineum Therapeutics's competitors and similar companies include Guizhou Sanli Pharmaceutical, EFFIK International, GSK and Laurus Labs.
 Contineum Therapeutics Contineum Therapeutics (formerly known as Pipeline Therapeutics) is a clinical-stage biopharmaceutical company focused on discovering and developing novel, oral small-molecule therapies for NI&I indications. |  Guizhou Sanli Pharmaceutical Guizhou Sanli Pharmaceutical (贵州三力制药股份有限公) researches and develops medicinal products. |  GSK GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. | |||
Founding Date | Founding Date 2017 | Founding Date 1995 | Founding Date 1992 | Founding Date 2000 | Founding Date 2005 |
Type | Type Public | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations An Shun Shi, CN HQ | Locations Anderlecht, BE HQ Meudon, FR | Locations London, GB HQ Boumerdes, DZ Buenos Aires, AR Abbotsford, AU Wien, AT Wavre, BE Rio De Janeiro, BR see more | Locations Hyderabad, IN HQ Hamburg, DE Turkapally, IN Visakhapatnam, IN Visakhapatnam, IN Visakhapatnam, IN Visakhapatnam, IN see more |
Employees | Employees 5124% increase | Employees 2,85225% increase | Employees 219 | Employees 68,629 | Employees 5,75359% increase |
Valuation ($) | Valuation ($) 440.1 m | Valuation ($) 796.5 m | Valuation ($) N/A | Valuation ($) 862.5 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥2.1b (FY, 2024) | Revenue (est.) N/A | Revenue (est.) £32.7b (FY, 2025) | Revenue (est.) ₹68.1b (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods ¥650m (FY, 2024) | Cost of goods N/A | Cost of goods £5.6b (FY, 2025) | Cost of goods ₹27b (FY, 2026) |
Gross profit | Gross profit N/A | Gross profit ¥1.5b (FY, 2024) | Gross profit N/A | Gross profit £28.5b (FY, 2025) | Gross profit ₹41.7b (FY, 2026) |
Net income | Net income ($60m) (FY, 2025) | Net income ¥279.8m (FY, 2024) | Net income N/A | Net income £6.3b (FY, 2025) | Net income ₹8.9b (FY, 2026) |
Funding | |||||
Total funding raised | Total funding raised $ 30m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 90m |
For sources of this data, please see the company profile
View Company Profiles
Guizhou Sanli Pharmaceutical
HQ
An Shun Shi, CN
Employees
2,852↑ 25% increase
Guizhou Sanli Pharmaceutical (贵州三力制药股份有限公) researches and develops medicinal products.
View company
EFFIK International
HQ
Anderlecht, BE
Employees
219
EFFIK International is a pharmaceutical laboratory.
View companyGSK
HQ
London, GB
Employees
68,629
GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products.
View company